PL4012035T3 - Wektory wirusowe związane z adenowirusami do leczenia jaskry miocylinowej (myoc) - Google Patents

Wektory wirusowe związane z adenowirusami do leczenia jaskry miocylinowej (myoc)

Info

Publication number
PL4012035T3
PL4012035T3 PL21204257.6T PL21204257T PL4012035T3 PL 4012035 T3 PL4012035 T3 PL 4012035T3 PL 21204257 T PL21204257 T PL 21204257T PL 4012035 T3 PL4012035 T3 PL 4012035T3
Authority
PL
Poland
Prior art keywords
myocilloidal
myoc
glaucoma
adenovirus
treatment
Prior art date
Application number
PL21204257.6T
Other languages
English (en)
Inventor
Peter Pechan
Abraham Scaria
Jeffery ARDINGER
Original Assignee
Genzyme Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corporation filed Critical Genzyme Corporation
Publication of PL4012035T3 publication Critical patent/PL4012035T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL21204257.6T 2014-09-16 2015-09-16 Wektory wirusowe związane z adenowirusami do leczenia jaskry miocylinowej (myoc) PL4012035T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462051229P 2014-09-16 2014-09-16

Publications (1)

Publication Number Publication Date
PL4012035T3 true PL4012035T3 (pl) 2025-03-24

Family

ID=54238590

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21204257.6T PL4012035T3 (pl) 2014-09-16 2015-09-16 Wektory wirusowe związane z adenowirusami do leczenia jaskry miocylinowej (myoc)

Country Status (5)

Country Link
ES (1) ES3011359T3 (pl)
HU (1) HUE070278T2 (pl)
PL (1) PL4012035T3 (pl)
PT (1) PT4012035T (pl)
WO (1) WO2016044478A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7226801B2 (ja) * 2016-08-16 2023-02-21 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 標的遺伝子導入のための方法および組成物
AR121769A1 (es) * 2020-04-06 2022-07-06 Alnylam Pharmaceuticals Inc Composiciones y métodos para el silenciamiento de la expresión de myoc
MX2023003699A (es) * 2020-10-07 2023-04-21 Regenxbio Inc Virus adenoasociados para el suministro ocular de genoterapia.
AU2022283898A1 (en) * 2021-06-03 2024-01-04 Dyno Therapeutics, Inc. Capsid variants and methods of using the same
WO2023278406A1 (en) * 2021-06-28 2023-01-05 Alnylam Pharmaceuticals, Inc. Compositions and methods for silencing myoc expression

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001523959A (ja) 1997-04-21 2001-11-27 ユニバーシティ オブ フロリダ 疾患のリボザイム処置のための物質および方法
US6566118B1 (en) 1997-09-05 2003-05-20 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
ATE403715T1 (de) 1999-08-09 2008-08-15 Targeted Genetics Corp Erhöhung der expression einer einzelsträngigen, heterologen nukleotidsequenz von einem rekombinanten viralen vektor durch ausgestaltung der sequenz in einer art und weise, dass basenpaarungen innerhalb der sequenz entstehen
NZ522840A (en) 2000-06-01 2004-12-24 Univ North Carolina A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together
CN103555677B (zh) 2001-11-13 2018-01-30 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
GB0403600D0 (en) * 2004-02-18 2004-03-24 Trinity College Dublin Methods and reagents for treating disease
WO2005117938A2 (en) * 2004-04-13 2005-12-15 Regents Of The University Of Minnesota Methods of treating ocular conditions
US7765583B2 (en) 2005-02-28 2010-07-27 France Telecom System and method for managing virtual user domains
WO2006119432A2 (en) 2005-04-29 2006-11-09 The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
KR20100061792A (ko) * 2007-10-01 2010-06-09 알콘 리서치, 리미티드 안 질환을 치료 또는 예방하기 위한 간섭 ｒｎａ 분자의 자기-상보적 ａａｖ 매개 전달
US20100081707A1 (en) 2008-02-21 2010-04-01 Ali Robin R Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
US8663624B2 (en) 2010-10-06 2014-03-04 The Regents Of The University Of California Adeno-associated virus virions with variant capsid and methods of use thereof
ES2724800T3 (es) 2011-02-17 2019-09-16 Univ Pennsylvania Composiciones y métodos para alterar la especificidad de tejido y mejorar la transferencia génica mediada por AAV9

Also Published As

Publication number Publication date
HUE070278T2 (hu) 2025-05-28
WO2016044478A1 (en) 2016-03-24
ES3011359T3 (en) 2025-04-07
PT4012035T (pt) 2025-02-11

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
EP3558393A4 (en) ADENO-ASSOCIATED VIRAL VECTORS
IL264143B (en) Processes for preparing olaparib
HUE059158T2 (hu) Eljárás pridopidin elõállítására
IL246588A0 (en) High titer production of adeno-associated virus vectors
EP3420388A4 (en) PUPILS EQUALIZATION
IL251178A0 (en) Adeno-associated viral vectors for treating myocilin (myoc) glaucoma
DK3145949T3 (da) Lentivirale vektorer
DK3108000T3 (da) Adeno-associeret virusvektor
DK3466432T3 (da) Fremgangsmåder til behandling af pulmonale non-tuberkuløse mykobakterielle infektioner
DK3492632T3 (da) Metoder til behandling af lithiumholdige materialer
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3134530T3 (da) Behandling af hyperbilirubinæmi
HUE058257T2 (hu) Eljárások oxatiazin-jellegû vegyületek elõállítására
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
BR112016022976A2 (pt) Métodos para o tratamento de hcv
HUE053443T2 (hu) Heteroaril vegyületek szembetegségek kezelésére
DK3113795T3 (da) Rekombinante virale isfahan-vektorer
HUE049170T2 (hu) Eljárás szubsztituált cikloszerinek elõállítására
HUE045704T2 (hu) Eljárás 5-fluor-1H-pirazolok elõállítására hexafluorpropénbõl kiindulva
DK3209295T3 (da) Fremgangsmåder til behandling af øjenlidelser
EP3493821A4 (en) METHOD OF TREATING THE RESPIRATORY TRACT
EP3498837A4 (en) Genome editing method
HUE047756T2 (hu) Eljárás metil-merkaptán elõállítására
PL4012035T3 (pl) Wektory wirusowe związane z adenowirusami do leczenia jaskry miocylinowej (myoc)